Skip to main content
. 2020 Oct 31;8:83. doi: 10.1186/s40560-020-00500-0

Table 2.

The summary results of all 23 studies

Results Primary outcomes Subgroup analyses
28 days 90 days ICU Hospital Low risk High risk VP VP analogs AT-II Refractory shock Septic shock
RR 0.92 0.95 0.96 1.08 0.91 0.97 0.95 0.91 0.85 0.84 0.94
95% CI lower bound 0.86 0.88 0.77 0.92 0.84 0.83 0.85 0.81 0.69 0.70 0.87
95% CI upper bound 0.99 1.04 1.20 1.27 0.98 1.15 1.06 1.02 1.06 0.998 1.01
P value 0.02* 0.26 0.73 0.35 0.02* 0.75 0.33 0.11 0.14 0.048* 0.11

ICU intensive care unit, VP vasopressin, AT-II angiotensin II, RR relative risk, CI confidence interval, *P < 0.05